Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Community Health Systems
CYH
$419M
| $3.15M | ﹤0.01% |
265,526
+17,300
| +7% | +$210K |
|
|
RVNC
1752
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.14M | ﹤0.01% |
161,250
+11,800
| +8% | +$179K |
|
1753
Radware
RDWR
$1.25B
| $3.14M | ﹤0.01% |
98,300
+7,700
| +8% | +$256K |
|
1754
Clean Energy Fuels
CLNE
$395M
| $3.14M | ﹤0.01% |
395,658
+27,700
| +8% | +$187K |
|
|
ONT
1755
Onterris Inc
ONT
$615M
| $3.14M | ﹤0.01% |
59,300
+10,400
| +21% | +$515K |
|
1756
OFG Bancorp
OFG
$2.26B
| $3.14M | ﹤0.01% |
117,800
+3,700
| +3% | +$103K |
|
|
INVX
1757
Innovex International
INVX
$2.15B
| $3.13M | ﹤0.01% |
83,700
+5,600
| +7% | +$161K |
|
|
ETWO
1758
DELISTED
E2open Parent Holdings
ETWO
| $3.13M | ﹤0.01% |
354,700
+24,600
| +7% | +$223K |
|
1759
Driven Brands
DRVN
$2.12B
| $3.12M | ﹤0.01% |
118,700
+8,200
| +7% | +$237K |
|
1760
Enerpac Tool Group
EPAC
$1.89B
| $3.12M | ﹤0.01% |
142,500
+9,600
| +7% | +$182K |
|
|
PTRA
1761
DELISTED
Proterra Inc. Common Stock
PTRA
| $3.11M | ﹤0.01% |
413,000
+39,300
| +11% | +$318K |
|
1762
ACV Auctions
ACVA
$1.35B
| $3.1M | ﹤0.01% |
209,600
+114,900
| +121% | +$1.6M |
|
1763
Brookdale Senior Living
BKD
$3B
| $3.09M | ﹤0.01% |
438,239
+29,100
| +7% | +$178K |
|
1764
Enanta Pharmaceuticals
ENTA
$391M
| $3.08M | ﹤0.01% |
43,300
+3,300
| +8% | +$215K |
|
1765
Editas Medicine
EDIT
$432M
| $3.08M | ﹤0.01% |
161,700
+11,900
| +8% | +$221K |
|
|
DVAX
1766
DELISTED
Dynavax Technologies
DVAX
| $3.07M | ﹤0.01% |
283,578
+30,400
| +12% | +$369K |
|
1767
Establishment Labs
ESTA
$2.25B
| $3.06M | ﹤0.01% |
45,400
+3,600
| +9% | +$210K |
|
1768
Laureate Education
LAUR
$5.15B
| $3.06M | ﹤0.01% |
258,200
+18,200
| +8% | +$221K |
|
1769
Relay Therapeutics
RLAY
$4.37B
| $3.06M | ﹤0.01% |
102,200
+8,800
| +9% | +$214K |
|
1770
Celestica
CLS
$43.8B
| $3.06M | ﹤0.01% |
257,400
+18,200
| +8% | +$215K |
|
1771
CryoPort
CYRX
$766M
| $3.06M | ﹤0.01% |
87,500
+6,400
| +8% | +$242K |
|
1772
M/I Homes
MHO
$3.9B
| $3.05M | ﹤0.01% |
68,800
+4,300
| +7% | +$219K |
|
1773
Deluxe
DLX
$1.11B
| $3.04M | ﹤0.01% |
100,700
+7,500
| +8% | +$236K |
|
1774
US Physical Therapy
USPH
$1.24B
| $3.03M | ﹤0.01% |
30,500
+2,000
| +7% | +$191K |
|
1775
Primoris Services
PRIM
$4.35B
| $3.03M | ﹤0.01% |
127,200
+8,500
| +7% | +$219K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.